V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003505 | 10002226 | 0 | 66.2 | Curative (C) | 2018-12-05 | 2018-12-20 | CAPECITABINE + RT | N | Y | 10480632 | CAPECITABINE + RT |
| 10003506 | 10002227 | 0 | 77.8 | Curative (C) | 2018-05-05 | 2018-05-21 | Cisplatin | 02 | N | 10480639 | AZACITIDINE |
| 10003507 | 10002228 | 1.65 | 53.2 | Disease modification (D) | 2016-10-06 | 2016-10-06 | CISPLATIN + RT | 02 | N | 10480647 | CISPLATIN + RT |
| 10003508 | 10002228 | 1.78 | 68 | Curative (C) | 2015-10-11 | 2015-10-29 | Cisplatin + Radiotherapy | N | Y | 10480647 | CISPLATIN + RT |
| 10003509 | 10002229 | 1.84 | 104.5 | Adjuvant (A) | 2018-11-27 | 2018-12-19 | Bortezomib + Cyclophos + Dex | 02 | Y | 10480685 | CAPECITABINE + GEMCITABINE |
| 10003510 | 10002229 | 1.77 | 0 | Neo-adjuvant (N) | null | 2017-09-12 | EC | N | Y | 10480685 | FLUOROURACIL + MITOMYCIN + RT |
| 10003511 | 10002230 | 1.64 | 63.1 | Adjuvant (A) | 2015-05-22 | 2015-05-22 | Cisplatin 7 day | 02 | N | 10480763 | PACLITAXEL |
| 10003512 | 10002231 | 1.78 | 91.1 | Disease modification (D) | 2014-09-17 | 2014-09-17 | Gemcitabine + Capecitabine | N | N | 10480769 | BORTEZOMIB |
| 10003513 | 10002232 | 1.6 | 57 | Curative (C) | 2016-04-29 | 2016-05-16 | Temozolomide + RT | 02 | N | 10480824 | TEMOZOLOMIDE + RT |
| 10003514 | 10002233 | null | 78.1 | Disease modification (D) | 2015-12-12 | 2015-12-12 | ABVD | N | null | 10480831 | CHOP |
| 10003515 | 10002234 | 1.7 | 86.6 | Disease modification (D) | 2015-03-11 | 2015-04-07 | Gemcitabine + Capecitabine | N | N | 10480843 | FLUOROURACIL + MITOMYCIN + RT |
| 10003516 | 10002235 | null | 81.8 | Palliative (P) | 2017-11-26 | 2017-11-26 | CISPLATIN + ETOPOSIDE | 2 | N | 10480854 | CTD |
| 10003517 | 10002236 | 1.75 | 70 | Curative (C) | 2015-12-06 | 2015-12-31 | Temozolomide + RT | 02 | Y | 10480861 | PACLITAXEL |
| 10003518 | 10006442 | 1.67 | 71 | Disease modification (D) | 2014-09-25 | 2014-10-23 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | 10480880 | CAPECITABINE + GEMCITABINE |
| 10003519 | 10002237 | 1.76 | 88.7 | Palliative (P) | 2017-08-02 | 2017-08-09 | Bortezomib +/- Dexamethasone | N | N | 10480895 | AZACITIDINE |
| 10003520 | 10002238 | 1.53 | 81.6 | Neo-adjuvant (N) | 2018-09-07 | 2018-09-07 | ABVD | 2 | N | 10480916 | BORTEZOMIB |
| 10003521 | 10002239 | null | 115.8 | Curative (C) | 2016-12-30 | 2017-01-21 | Cisplatin + Radiotherapy | 02 | Y | 10480918 | CISPLATIN + RT |
| 10003522 | 10002239 | 1.65 | 83.5 | Radical (R) | 2013-11-28 | 2013-12-17 | BCG Intravesical | N | N | 10480918 | FLUOROURACIL + MITOMYCIN + RT |
| 10003523 | 10002240 | 1.65 | 82 | Curative (C) | 2019-01-19 | 2019-01-24 | Bortezomib +/- Dexamethasone | N | N | 10481004 | EC |
| 10003524 | 10006444 | null | 79.5 | Palliative (P) | 2017-01-23 | 2017-01-26 | ABVD | N | N | 10481014 | CVD |
| 10003525 | 10006444 | 1.71 | 86.8 | Curative (C) | 2017-01-21 | 2017-01-31 | Gemcitabine + Capecitabine | 02 | N | 10481014 | CISPLATIN |
| 10003526 | 10002241 | 1.72 | 87 | null | 2018-12-16 | 2018-12-23 | CAPECITABINE + RT | 02 | Y | 10481039 | CAPECITABINE + RT |
| 10003527 | 10002242 | 1.69 | 88.7 | Palliative (P) | 2017-11-25 | 2017-12-07 | CISPLATIN + ETOPOSIDE | 02 | Y | 10481040 | BORTEZOMIB |
| 10003528 | 10006445 | 1.8 | 71 | Adjuvant (A) | null | 2017-08-03 | EC | N | N | 10481116 | FLUOROURACIL + MITOMYCIN + RT |
| 10003529 | 10006445 | 1.75 | 0 | Curative (C) | 2016-05-26 | 2016-06-10 | Capecitabine 42days + RT | N | Y | 10481116 | CAPECITABINE + RT |
| 10003530 | 10002243 | 1.7 | 69.5 | Curative (C) | 2016-11-30 | 2016-12-21 | Cisplatin + Radiotherapy | N | Y | 10481193 | CISPLATIN + RT |
| 10003531 | 10002244 | 1.88 | 0 | Curative (C) | 2013-08-09 | 2013-08-24 | Capecitabine + Cisplatin | 02 | N | 10481271 | CAPECITABINE + CISPLATIN |
| 10003532 | 10002245 | 1.54 | 62.4 | Palliative (P) | 2017-03-13 | 2017-03-19 | CHOP - 21 days | N | N | 10481273 | CVD |
| 10003533 | 10002245 | null | 58.5 | Curative (C) | null | 2017-09-07 | EC | N | N | 10481273 | AZACITIDINE |
| 10003534 | 10002246 | 1.79 | 68.7 | Curative (C) | 2018-10-15 | 2018-11-09 | Abiraterone | 2 | N | 10481371 | IMATINIB |
| 10003535 | 10002247 | null | 86.8 | Palliative (P) | 2016-04-06 | 2016-05-04 | FLUOROURACIL | null | Y | 10481388 | FLUOROURACIL |
| 10003536 | 10002247 | 1.77 | 112 | Not known (9) | 2015-02-27 | 2015-03-17 | Chlorambucil | N | N | 10481388 | CAPECITABINE + GEMCITABINE |
| 10003537 | 10002248 | null | null | Palliative (P) | 2017-04-08 | 2017-04-18 | Irinotecan + Modified De Gramont | N | N | 10481441 | IRINOTECAN + MDG |
| 10003538 | 10002248 | 1.65 | 74.7 | Adjuvant (A) | 2017-02-10 | 2017-02-10 | Fluorouracil + Folinic Acid Weekly | 2 | N | 10481441 | FLUOROURACIL |
| 10003539 | 10002249 | null | null | Palliative (P) | 2015-08-27 | 2015-09-01 | Paclitaxel 7 day | N | N | 10481457 | IMATINIB |
| 10003540 | 10002249 | 1.64 | 58.2 | Adjuvant (A) | 2017-04-02 | 2017-04-09 | Capecitabine 35days + RT | N | N | 10481457 | CAPECITABINE + RT |
| 10003541 | 10002250 | 1.88 | 68.6 | Adjuvant (A) | 2015-07-09 | 2015-07-09 | FLUOROURACIL | 2 | N | 10481482 | FLUOROURACIL |
| 10003542 | 10002250 | 1.82 | 0 | Adjuvant (A) | 2018-06-22 | 2018-06-30 | CTD | 02 | N | 10481482 | FLUOROURACIL + MITOMYCIN + RT |
| 10003543 | 10002250 | 1.63 | 78.3 | Disease modification (D) | 2016-10-13 | 2016-10-20 | ABVD | 2 | N | 10481482 | CHLORAMBUCIL |
| 10003544 | 10002250 | 1.57 | 120.6 | Palliative (P) | 2018-12-28 | 2018-12-28 | Irinotecan + Modified De Gramont | 02 | N | 10481482 | IRINOTECAN + MDG |
| 10003545 | 10002251 | 1.73 | null | null | 2018-12-12 | 2019-01-02 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | null | 10481582 | CTD |
| 10003546 | 10002251 | 1.75 | 80 | Adjuvant (A) | 2016-04-14 | 2016-05-05 | Bortezomib + Cyclophos + Dex | N | Y | 10481582 | CVD |
| 10003547 | 10002251 | 0 | 95.5 | Adjuvant (A) | 2016-03-05 | 2016-03-11 | Chlorambucil | N | N | 10481582 | EC |
| 10003548 | 10002252 | 1.8 | 61.6 | Neo-adjuvant (N) | 2017-09-24 | 2017-09-26 | Chlorambucil | 2 | N | 10481736 | BCG |
| 10003549 | 10002253 | 1.65 | 70 | Palliative (P) | 2016-05-25 | 2016-06-14 | Capecitabine + Cisplatin | 2 | Y | 10481834 | CAPECITABINE + CISPLATIN |
| 10003550 | 10002254 | 1.62 | 68 | Disease modification (D) | 2017-06-04 | 2017-06-10 | Capecitabine + Cisplatin | 02 | N | 10481844 | TEMOZOLOMIDE + RT |
| 10003551 | 10006452 | 1.66 | null | Disease modification (D) | 2016-07-16 | 2016-07-16 | CISPLATIN + ETOPOSIDE | 99 | N | 10481880 | PACLITAXEL |
| 10003552 | 10002255 | null | null | Palliative (P) | 2016-11-26 | 2016-12-05 | FLUOROURACIL + MITOMYCIN + RT | null | N | 10481885 | CHLORAMBUCIL |
| 10003553 | 10006453 | null | 60.8 | Curative (C) | 2017-07-10 | 2017-07-28 | Capecitabine 35days + RT | N | Y | 10481914 | CAPECITABINE + RT |
| 10003554 | 10002256 | null | 96 | Adjuvant (A) | 2018-08-07 | 2018-08-07 | ABVD | N | null | 10481931 | BORTEZOMIB |